About the webinar:
Genetically engineered mouse and rat models are critical in advancing fundamental research, as well as the discovery and development of therapeutics intended to treat human disease. While such models were often challenging to produce, the advent of technologies such as CRISPR/Cas9 have lowered the barrier to entry and resulted in many more options. While CRISPR/Cas9 is an efficient and popular model generation technique, it is only part of an ideal and complete model generation toolkit.
There are many considerations that come into play when selecting the appropriate model generation technique for your new mouse or rat model. CRISPR/Cas9 may be a solid option, but often times homologous recombination (HR) in ES cells or transgenesis may be more appropriate.
In this exclusive webinar, you will learn why working with a model provider that is licensed to utilize different model generation techniques is critical for generating the right model for your study. Dr. Patrick Gordon will explore multiple case studies that demonstrate the potential costs and/or benefits of seemingly small choices in the model generation process, and identify how they may have significant consequences.
Attend this webinar to:
- Discover how Taconic compares to other commercial model generation providers
- Understand how your research program can benefit from Taconic key differentiators and scientific expertise
- Uncover how small decisions made (or overlooked) during project design can have significant unintended impacts on timelines, cost, and quality, risking an entire research project or program.
